Cargando…
Visualization of angiogenesis during cancer development in the polyoma middle T breast cancer model: molecular imaging with (R)-[(11)C]PAQ
BACKGROUND: Vascular endothelial growth factor receptor 2 (VEGFR2) is a crucial mediator of tumour angiogenesis. High expression levels of the receptor have been correlated to poor prognosis in cancer patients. Reliable imaging biomarkers for stratifying patients for anti-angiogenic therapy could th...
Autores principales: | Samén, Erik, Lu, Li, Mulder, Jan, Thorell, Jan-Olov, Damberg, Peter, Tegnebratt, Tetyana, Holmgren, Lars, Rundqvist, Helene, Stone-Elander, Sharon |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3986910/ https://www.ncbi.nlm.nih.gov/pubmed/24670127 http://dx.doi.org/10.1186/2191-219X-4-17 |
Ejemplares similares
-
Treatment response assessment with (R)-[(11)CPAQ PET in the MMTV-PyMT mouse model of breast cancer
por: Tegnebratt, T., et al.
Publicado: (2018) -
Glycolytic Response to Inflammation Over Time: Role of Myeloid HIF-1alpha
por: Fitzpatrick, Susan F., et al.
Publicado: (2018) -
Combining [(11)C]-AnxA5 PET Imaging with Serum Biomarkers for Improved Detection in Live Mice of Modest Cell Death in Human Solid Tumor Xenografts
por: Cheng, Qing, et al.
Publicado: (2012) -
Preclinical PET imaging of EGFR levels: pairing a targeting with a non-targeting Sel-tagged Affibody-based tracer to estimate the specific uptake
por: Cheng, Qing, et al.
Publicado: (2016) -
[(18) F]FDG-PET imaging is an early non-invasive pharmacodynamic biomarker for a first-in-class dual MEK/Raf inhibitor, RO5126766 (CH5126766), in preclinical xenograft models
por: Tegnebratt, Tetyana, et al.
Publicado: (2013)